focus -WSS

focus

author：fashion 2025-08-12 09:13:20 - browse：699

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Health tech startups drop sharply from 2021 highs

WSS

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Neuroscience startup Neumora files for IPO

Kaiser Permanente unions announce official strike date

How one patient went off dialysis — and others can too

Departing Stanford president retracts two papers

How the Dana

hotspot

focus

explore

In Memoriam: Notable people who died in 2023

WHO recommends dropping component of many flu vaccines

Novavax promises a turnaround & Lilly roils the obesity market

Why more medical students aren't specializing in primary care

Malaria cases in Florida and Texas: Here’s what you need to know

Why more medical students aren't specializing in primary care

Hepatitis C has a cure — but many Americans still lack access to it

Appeals court upholds limits to abortion pill

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

entertainment

Menendez indictment could see pharma lose a key ally

Shingles, which affected Dianne Feinstein, is on the rise

Shingles, which affected Dianne Feinstein, is on the rise

2024 GOP presidential candidates spar over abortion in debate

After a drawn out lobbying fight, ARPA

Ionis has late

leisure time

leisure time

hotspot

leisure time